237 related articles for article (PubMed ID: 22448022)
1. New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future.
Lienhardt C; Raviglione M; Spigelman M; Hafner R; Jaramillo E; Hoelscher M; Zumla A; Gheuens J
J Infect Dis; 2012 May; 205 Suppl 2():S241-9. PubMed ID: 22448022
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes.
Lienhardt C; Vernon A; Raviglione MC
Curr Opin Pulm Med; 2010 May; 16(3):186-93. PubMed ID: 20216421
[TBL] [Abstract][Full Text] [Related]
4. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
5. Rip Van Winkle wakes up: development of tuberculosis treatment in the 21st century.
Burman WJ
Clin Infect Dis; 2010 May; 50 Suppl 3():S165-72. PubMed ID: 20397944
[TBL] [Abstract][Full Text] [Related]
6. Treatment and prevention of tuberculosis in HIV-infected persons.
Cohn DL
Infect Dis Clin North Am; 1994 Jun; 8(2):399-412. PubMed ID: 8089467
[TBL] [Abstract][Full Text] [Related]
7. New anti-tuberculosis drugs in clinical trials with novel mechanisms of action.
Rivers EC; Mancera RL
Drug Discov Today; 2008 Dec; 13(23-24):1090-8. PubMed ID: 18840542
[TBL] [Abstract][Full Text] [Related]
8. Toward an optimized therapy for tuberculosis? Drugs in clinical trials and in preclinical development.
Ma Z; Lienhardt C
Clin Chest Med; 2009 Dec; 30(4):755-68, ix. PubMed ID: 19925965
[TBL] [Abstract][Full Text] [Related]
9. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment.
Showalter HD; Denny WA
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S3-17. PubMed ID: 18762151
[TBL] [Abstract][Full Text] [Related]
10. Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities.
Lienhardt C; Davies G
Int J Tuberc Lung Dis; 2010 May; 14(5):528-37. PubMed ID: 20392344
[TBL] [Abstract][Full Text] [Related]
11. Managing TB in the 21st century: existing and novel drug therapies.
Guy ES; Mallampalli A
Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
[TBL] [Abstract][Full Text] [Related]
12. Rising standards for tuberculosis drug development.
Balganesh TS; Alzari PM; Cole ST
Trends Pharmacol Sci; 2008 Nov; 29(11):576-81. PubMed ID: 18799223
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic review: tuberculosis.
Houston S; Pozniak A; Ray CS
Cent Afr J Med; 1991 Aug; 37(8):250-9. PubMed ID: 1807799
[TBL] [Abstract][Full Text] [Related]
14. Treatment of tuberculosis.
Lordi GM; Reichman LB
Am Fam Physician; 1991 Jul; 44(1):219-24. PubMed ID: 2058533
[TBL] [Abstract][Full Text] [Related]
15. Challenges and opportunities in developing novel drugs for TB.
Kaneko T; Cooper C; Mdluli K
Future Med Chem; 2011 Sep; 3(11):1373-400. PubMed ID: 21879843
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis: the drug development pipeline at a glance.
Villemagne B; Crauste C; Flipo M; Baulard AR; Déprez B; Willand N
Eur J Med Chem; 2012 May; 51():1-16. PubMed ID: 22421275
[TBL] [Abstract][Full Text] [Related]
17. HIV-associated tuberculosis: clinical update.
Swaminathan S; Padmapriyadarsini C; Narendran G
Clin Infect Dis; 2010 May; 50(10):1377-86. PubMed ID: 20388036
[TBL] [Abstract][Full Text] [Related]
18. The Global TB Drug Facility: innovative global procurement.
Kumaresan J; Smith I; Arnold V; Evans P
Int J Tuberc Lung Dis; 2004 Jan; 8(1):130-8. PubMed ID: 14974756
[TBL] [Abstract][Full Text] [Related]
19. Pediatric tuberculosis: global overview and challenges.
Swaminathan S; Rekha B
Clin Infect Dis; 2010 May; 50 Suppl 3():S184-94. PubMed ID: 20397947
[TBL] [Abstract][Full Text] [Related]
20. New drugs for tuberculosis treatment.
Sánchez F; López Colomés JL; Villarino E; Grosset J
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():47-56. PubMed ID: 21420567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
